Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DIDANOSINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 385 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Romano, L; Venturi, G; Vivarelli, A; Galli, L; Zazzi, M
      Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple

      CLINICAL INFECTIOUS DISEASES
    2. Chang, SN; Griesgraber, G; Wagner, CR
      Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2 ',3 '-dideoxyadenosine (DDA) and 3 '-azido-3 '-deoxythymidine (AZT)

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    3. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Deeks, SG; Barditch-Crovo, P; Collier, A; Smith, A; Miller, M; McGowan, M; Coakley, DF
      Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Kunches, LM; Reinhalter, NE; Marquis, A; Coakley, E; Cohen, C; Morris, AB; Mazzullo, JM
      Tolerability of enteric-coated didanosine capsules compared with didanosine tablets in adults with HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Knobel, H; Miro, TM; Domingo, P; Rivero, A; Marquez, M; Force, L; Gonzalez, A; De Miguel, V; Sanz, J; Boix, V; Blanco, JL; Locutura, J
      Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo- controlled trial: The GESIDA 09/99 study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Mole, L; Schmidgall, D; Holodniy, Y
      A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Coull, JJ; Turner, D; Melby, T; Betts, MR; Lanier, R; Margolis, DM
      A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
      Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
      Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens

      SEXUALLY TRANSMITTED INFECTIONS
    16. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    17. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    18. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
      Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens

      JOURNAL OF HUMAN VIROLOGY
    19. Weinberg, A
      In vitro hydroxyurea decreases th1 cell-mediated immunity

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    20. Bersoff-Matcha, SJ; Miller, WC; Aberg, JA; van der Horst, C; Hamrick, HJ; Powderly, WG; Mundy, LM
      Sex differences in nevirapine rash

      CLINICAL INFECTIOUS DISEASES
    21. Lafeuillade, A
      Factors affecting adherence and convenience in antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    22. Curi, ALL; Freeman, G; Kapembwa, M; Pavesio, C
      Retinal toxicity due to Efavirenz

      EYE
    23. Kline, MW; Brundage, RC; Fletcher, CV; Schwarzwald, H; Calles, NR; Buss, NE; Snell, P; Delora, P; Eason, M; Jorga, K; Craig, C; Duff, F
      Combination therapy with saquinavir soft gelatin capsules in children withhuman immunodeficiency virus infection

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    24. Abrams, EJ; Weedon, J; Bertolli, J; Bornschlegel, K; Cervia, J; Mendez, H; Lambert, G; Singh, T; Thomas, P
      Aging cohort of perinatally human immunodeficiency virus-infected childrenin New York City

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    25. Ross, L; Liao, QM; Gao, HT; Pham, S; Tolson, J; Hertogs, K; Larder, B; Saag, MS
      Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    26. Ross, L; Scarsella, A; Raffanti, S; Henry, K; Becker, S; Fisher, R; Liao, QM; Hirani, A; Graham, N; St Clair, M; Hernandez, J
      Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    27. Cahours, X; Tran, TT; Mesplet, N; Kieda, C; Morin, P; Agrofoglio, LA
      Analysis of intracellular didanosine triphosphate at sub-ppb level using LC-MS/MS

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    28. Tatsunami, S; Ito, A; Kawata, K; Kuwabara, R; Yamada, K
      Determination of pharmacokinetic parameters of stavudine in Japanese patients infected with HIV-1, using a Gaussian-like input rate function

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    29. Betageri, GV; Deshmukh, DV; Gupta, RB
      Oral sustained-release bioadhesive tablet formulation of didanosine

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    30. Bruno, R; Regazzi, MB; Ciappina, V; Villani, P; Sacchi, P; Montagna, M; Panebianco, R; Filice, G
      Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV

      CLINICAL PHARMACOKINETICS
    31. Shulman, N; Zolopa, AR; Passaro, D; Shafer, RW; Huang, W; Katzenstein, D; Israelski, DM; Hellmann, N; Petropoulos, C; Whitcomb, J
      Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy

      AIDS
    32. Pellegrin, I; Garrigue, I; Caumont, A; Pellegrin, JL; Merel, P; Schrive, MH; Bonot, P; Fleury, H
      Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to astavudine-containing regimen

      AIDS
    33. Soriano, V
      Sequencing antiretroviral drugs

      AIDS
    34. Moore, RD; Keruly, JC; Chaisson, RE
      Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs

      AIDS
    35. Foli, A; Benvenuto, F; Piccinini, G; Bareggi, A; Cossarizza, A; Lisziewicz, J; Lori, F
      Direct analysis of mitochondrial toxicity of antiretroviral drugs

      AIDS
    36. Bartlett, JA; DeMasi, R; Quinn, J; Moxham, C; Rousseau, F
      Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

      AIDS
    37. Havlir, DV; Gilbert, PB; Bennett, K; Collier, AC; Hirsch, MS; Tebas, P; Adams, EM; Wheat, LJ; Goodwin, D; Schnittman, S; Holohan, MK; Richman, DD
      Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

      AIDS
    38. Conway, B; Wainberg, MA; Hall, D; Harris, M; Reiss, P; Cooper, D; Vella, S; Curry, R; Robinson, P; Lange, JMA; Montaner, JSG
      Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine

      AIDS
    39. Feigal, D
      Who's on first? What's on second?

      CONTROLLED CLINICAL TRIALS
    40. Smeaton, LM; DeGruttola, V; Robbins, GK; Shafer, RW
      ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1

      CONTROLLED CLINICAL TRIALS
    41. Pellegrin, I; Breilh, D; Birac, V; Deneyrolles, M; Mercie, P; Trylesinski, A; Neau, D; Saux, MC; Fleury, HJA; Pellegrin, JL
      Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens

      THERAPEUTIC DRUG MONITORING
    42. Lake-Bakaar, G; Mazzoccoli, V; Dickman, K; Lyubsky, S
      Differential effects of nucleoside analogs on oxidative phosphorylation inhuman pancreatic cells

      DIGESTIVE DISEASES AND SCIENCES
    43. Sarmati, L; Nicastri, E; Parisi, SG; D'Ettorre, G; Narciso, P; Mancino, G; Gallo, I; Abbadessa, V; Dalle, NER; Traina, C; Vullo, V; Andreoni, M
      Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations

      JOURNAL OF MEDICAL VIROLOGY
    44. Izzedine, H; Launay-Vacher, V; Baumelou, A; Deray, G
      An appraisal of antiretroviral drugs in hemodialysis

      KIDNEY INTERNATIONAL
    45. Masquelier, B; Race, E; Tamalet, C; Descamps, D; Izopet, J; Buffet-Janvresse, C; Ruffault, A; Mohammed, AS; Cottalorda, J; Schmuck, A; Calvez, V; Dam, E; Fleury, H; Brun-Vezinet, F
      Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    46. Eyer-Silva, WA; Arabe, J; Pinto, JFC; Morais-De-Sa, CA
      Macrocytosis in patients on stavudine

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    47. Saez-Llorens, X; Nelson, RP; Emmanuel, P; Wiznia, A; Mitchell, C; Church, JA; Sleasman, J; Van Dyke, R; Richardson, CG; Cutrell, A; Spreen, W; Hetherington, S
      A randomized, double-blind study of triple nucleoside therapy of abacavir,lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children

      PEDIATRICS
    48. Dolce, V; Fiermonte, G; Runswick, MJ; Palmieri, F; Walker, JE
      The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    49. Johnson, AA; Ray, AS; Hanes, J; Suo, ZC; Colacino, JM; Anderson, KS; Johnson, KA
      Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    50. Boelaert, JR; Sperber, K; Piette, J
      The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea

      BIOCHEMICAL PHARMACOLOGY
    51. Aboulker, JP; Babiker, A; Darbyshire, JH; Debre, M; Giaquinto, C; Gibb, DM; Harper, L; Newberry, A; Saidi, Y; Levy, J; Della Negra, M; Forbes, J; Vaudry, W; Mechinaud, F; Nicolas, J; Wahn, V; Dammann, C; Notheis, G; Hinkelmann, B; Butler, K; Giaquinto, C; De Manzini, A; Mazza, A; Duse, M; Loy, A; Plebani, A; Castelli-Gattinara, G; Cellini, M; Palomba, E; Caselli, D; Guarino, A; Osimani, P; Scherpbier, H; Delgado, A; Gomez, ID; Lecuona, JE; Pena, MJM; Baselga, C; Leal, JAL; Amador, JTR; Canosa, C; Sierra, AM; Calavia, LC; Rodrigo, C; Guasch, CF; Bohlin, A; Nadal, D; Mok, J; Lyall, H; Novelli, V; Sharland, M; Sloper, K
      Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

      ARCHIVES OF DISEASE IN CHILDHOOD
    52. Pellegrin, I; Segondy, M; Garrigue, I; Izopet, J; Montes, B; Pellegrin, JL; Reynes, J; Massip, P; Puel, J; Fleury, H
      Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    53. Biron, F; Ponceau, B; Bouhour, D; Boibieux, A; Verrier, B; Peyramond, D
      Long-term safety and antiretroviral activity of hydroxyurea and didanosinein HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    54. Heredia, A; Davis, C; Redfield, R
      Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    55. van der Ende, ME; Guillon, C; Boers, PHM; Ly, TD; Gruters, RA; Osterhaus, ADME; Schutten, M
      Antiviral resistance of biologic HIV-2 clones obtained from individuals onnucleoside reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    56. Garcia, F; Alonso, MM; Romeu, J; Knobel, H; Arrizabalaga, J; Ferrer, E; Dalmau, D; Ruiz, I; Vidal, F; Frances, A; Segura, F; Gomez-Sirvent, JL; Cruceta, A; Clotet, B; Pumarola, T; Gallart, T; O'Brien, WA; Miro, JM; Gatell, JM
      Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    57. Kazatchkine, MD; Van, PN; Costagliola, D; Mohammed, AS; Ledeine, JM; Troccaz, M; Belec, L
      Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    58. Currier, JS; Spino, C; Grimes, J; Wofsy, CB; Katzenstein, DA; Hughes, MD; Hammer, SM; Cotton, DJ
      Differences between women and men in adverse events and CD4(+) responses to nucleoside analogue therapy for HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    59. Rainey, PM; Friedland, G; McCance-Katz, EF; Andrews, L; Mitchell, SM; Charles, C; Jatlow, P
      Interaction of methadone with didanosine and stavudine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    60. Shulman, NS; Zolopa, AR; Passaro, DJ; Murlidharan, U; Israelski, DM; Brosgart, CL; Miller, MD; Van Doren, S; Shafer, RW; Katzenstein, DA
      Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    61. Morlat, P; Marimoutou, C; Dequae-Merchadou, L; Pellegrin, I; Mercie, I; Neau, D; Beylot, J; Dabis, F
      Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    62. Darbyshire, J
      Therapeutic interventions in HIV infection - a critical view

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    63. Jorgensen, LB; Katzenstein, TL; Gerstoft, J; Mathiesen, LR; Pedersen, C; Nielsen, C
      Genotypic and phenotypic nevirapine resistance correlates with virologicalfailure during salvage therapy including abacavir and nevirapine

      ANTIVIRAL THERAPY
    64. de Mendoza, C; Soriano, V; Perez-Olmeda, M; Rodriguez-Rosado, R; Gonzalez-Lahoz, J
      Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients

      JOURNAL OF HUMAN VIROLOGY
    65. Ross, L; Johnson, M; Ferris, RG; Short, SA; Boone, LR; Melby, TE; Lanier, R; Shaefer, M; St Clair, M
      Deletions in the beta 3-beta 4 hairpin loop of HIV-1 reverse transcriptaseare observed in HIV-1 isolated from subjects during long-term antiretroviral therapy

      JOURNAL OF HUMAN VIROLOGY
    66. Perez-Alvarez, L; Villahermosa, ML; Cuevas, MT; Delgado, E; Manjon, N; de Parga, EV; Medrano, L; Contreras, G; Thomson, MM; Colomo, C; Taboada, JA; Najera, R
      Single- and multidrug resistance mutations to reverse transcriptase and protease inhibitors - Human immunodeficiency virus type 1-infected patients from two geographical areas in Spain

      JOURNAL OF HUMAN VIROLOGY
    67. Gangar, M; Arias, G; O'Brien, JG; Kemper, CA
      Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine

      ANNALS OF PHARMACOTHERAPY
    68. Gibbs, MA; Sorensen, SJ
      Hydroxyurea in the treatment of HIV-1

      ANNALS OF PHARMACOTHERAPY
    69. Zala, C; Rouleau, D; Montaner, JSG
      Role of hydroxyurea in treatment of disease due to human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    70. Lori, F; Lisziewicz, J
      Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug

      CLINICAL INFECTIOUS DISEASES
    71. McCarthy, WF; Gable, J; Lawrence, J; Thompson, M
      A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    72. Pillay, D; Taylor, S; Richman, DD
      Incidence and impact of resistance against approved antiretroviral drugs

      REVIEWS IN MEDICAL VIROLOGY
    73. Clarke, S; Harrington, P; Condon, C; Kelleher, D; Smith, OP; Mulcahy, F
      Late onset hepatitis and prolonged deterioration in hepatic function associated with nevirapine therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    74. Baldanti, F; Paolucci, S; Maserati, R; Maggiolo, F; Pan, A; Castelli, F; Gulminetti, R; Comolli, G; Chiesa, A; Gerna, G
      Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    75. Albrecht, MA; Hughes, MD; Liou, SH; Katzenstein, DA; Murphy, R; Balfour, HH; Para, MF; Valdez, H; Hammer, SM
      Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    76. Wald, JJ
      The effects of toxins on muscle

      NEUROLOGIC CLINICS
    77. Lori, F; Lisziewicz, J
      Role of immune modulation in primary HIV infection

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    78. Sharland, M; Gibb, D; Giaquinto, C
      Current evidence for the use of paediatric antiretroviral therapy - a PENTA analysis

      EUROPEAN JOURNAL OF PEDIATRICS
    79. Hainaut, M; Peltier, CA; Gerard, M; Marissens, D; Zissis, G; Levy, J
      Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1

      EUROPEAN JOURNAL OF PEDIATRICS
    80. Pijnenburg, MWH; Cotton, MF
      Monotherapy in an era of combination therapy: is there a benefit? Experience in HIV-1-infected symptomatic South African children

      ANNALS OF TROPICAL PAEDIATRICS
    81. Carr, A; Chuah, J; Hudson, J; French, M; Hoy, J; Law, M; Sayer, D; Emery, S; Cooper, DA
      A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

      AIDS
    82. van Heeswijk, RPG; Veldkamp, AI; Mulder, JW; Meenhorst, PL; Wit, FWNM; Lange, JMA; Danner, SA; Foudraine, NA; Kwakkelstein, MO; Reiss, P; Beijnen, JH; Hoetelmans, RMW
      The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

      AIDS
    83. Ravot, E; Tambussi, G; Jessen, H; Tinelli, C; Lazzarin, A; Lisziewicz, J; Lori, F
      Effects of hydroxyurea on T cell count changes during primary HIV infection

      AIDS
    84. Moore, RD; Wong, WME; Keruly, JC; McArthur, JC
      Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

      AIDS
    85. Casado, JL; Hertogs, K; Ruiz, L; Dronda, F; Van Cauwenberge, A; Arno, A; Garcia-Arata, I; Bloor, S; Bonjoch, A; Blazquez, J; Clotet, B; Larder, B
      Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

      AIDS
    86. Coakley, EP; Gillis, JM; Hammer, SM
      Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine

      AIDS
    87. Pollard, RB
      Didanosine once daily: potential for expanded use

      AIDS
    88. de Ronde, A; van Dooren, M; de Rooij, E; van Gemen, B; Lange, J; Goudsmit, J
      Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient

      AIDS
    89. Izopet, J; Massip, P; Souyris, C; Sandres, K; Puissant, B; Obadia, M; Pasquier, C; Bonnet, E; Marchou, B; Puel, J
      Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

      AIDS
    90. Rutschmann, OT; Vernazza, PL; Bucher, HC; Opravil, M; Ledergerber, B; Telenti, A; Malinverni, R; Bernasconi, E; Fagard, C; Leduc, D; Perrin, L; Hirschel, B
      Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection

      AIDS
    91. Barreiro, P; Soriano, V; Casas, E; Estrada, V; Tellez, MJ; Hoetelmans, R; de Requena, DG; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

      AIDS
    92. Kuritzkes, DR; Bassett, RL; Johnson, VA; Marschner, IC; Eron, JJ; Sommadossi, JP; Acosta, EP; Murphy, RL; Fife, K; Wood, K; Bell, D; Martinez, A; Pettinelli, CB
      Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370

      AIDS
    93. Eron, JJ; Murphy, RL; Peterson, D; Pottage, J; Parenti, DM; Jemsek, J; Swindells, S; Sepulveda, G; Bellos, N; Rashbaum, BC; Esinhart, J; Schoellkopf, N; Grosso, R; Stevens, M
      A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)

      AIDS
    94. Ruxrungtham, K; Kroon, EDMB; Ungsedhapand, C; Teeratakulpisarn, S; Ubolyam, S; Buranapraditkun, S; van Leeuwen, R; Weverling, GJ; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients

      AIDS
    95. Precious, HM; Gunthard, HF; Wong, JK; D'Aquila, RT; Johnson, VA; Kuritzkes, DR; Richman, DD; Brown, AJL
      Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy

      AIDS
    96. Johnson, D
      Principles of treating HIV

      SOUTH AFRICAN MEDICAL JOURNAL
    97. Cotton, MF
      Antiretroviral therapy in children - Increased benefit from increased complexity

      SOUTH AFRICAN MEDICAL JOURNAL
    98. Morse, GD; Reichman, RC; Fischl, MA; Para, M; Leedom, J; Powderly, W; Demeter, LM; Resnick, L; Bassiakos, Y; Timpone, J; Cox, S; Batts, D
      Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies

      ANTIVIRAL RESEARCH
    99. Nachman, SA; Stanley, K; Yogev, R; Pelton, S; Wiznia, A; Lee, S; Mofenson, L; Fiscus, S; Rathore, M; Jimenez, E; Borkowsky, W; Pitt, J; Smith, ME; Wells, B; McIntosh, K
      Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    100. Bacheler, LT; Anton, ED; Kudish, P; Baker, D; Bunville, J; Krakowski, K; Bolling, L; Aujay, M; Wang, XV; Ellis, D; Becker, MF; Lasut, AL; George, HJ; Spalding, DR; Hollis, G; Abremski, K
      Human immunodeficiency virus type 1 mutations selected in patients failingefavirenz combination therapy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 05:19:51